Diabetes Meds Deemed Equal, but Metformin Still First-Line

This article originally appeared here.
Share this content:
Diabetes Meds Deemed Equal, but Metformin Still First-Line
Diabetes Meds Deemed Equal, but Metformin Still First-Line

WEDNESDAY, July 20, 2016 (HealthDay News) -- There are no significant differences in the associations between available glucose-lowering drugs (alone or in combination) and the risk of cardiovascular or all-cause mortality, according to a review published in the July 19 issue of the Journal of the American Medical Association.

Suetonia Palmer, Ph.D., an associate professor in the Department of Medicine at the University of Otago in New Zealand, and colleagues analyzed results from 301 clinical trials testing nine classes of diabetes drugs. Many trials tested only a single medication, but over 100 studies used a drug in combination with metformin.

Overall, metformin worked as well, or better, than other drugs when it came to reducing blood glucose levels. When it came to preventing complications or lengthening patients' lives, no single drug or drug combination stood out.

"Metformin was associated with lower or no significant difference in hemoglobin A1c levels compared with any other drug classes. All drugs were estimated to be effective when added to metformin," the authors conclude. "These findings are consistent with American Diabetes Association recommendations for using metformin monotherapy as initial treatment for patients with type 2 diabetes and selection of additional therapies based on patient-specific considerations."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Low-Dose Hyaluronidase Can Remove Hyaluronic Acid Fillers

Low-Dose Hyaluronidase Can Remove Hyaluronic Acid Fillers

Greater resolution of nodules with hyaluronidase versus saline; more rapid resolution with higher doses

Improvement in Race-Based Disparities in Years of Life Lost

Improvement in Race-Based Disparities in Years of Life ...

Decline in race-based disparities in years of life lost seen in the United States from 1990 to 2014

Drug-Related Endocarditis Cases Up From 2007 to 2015

Drug-Related Endocarditis Cases Up From 2007 to 2015

Increase in endocarditis over nine-year study period mirrored increase in concomitant mixed drug use

is free, fast, and customized just for you!

Already a member?

Sign In Now »